Replies to post #100202 on Biotech Values

[Shengli]

I believe that prior to the use of rib (i.e. when ifn monotherapy was the primary treatment for HCV) SVR was 12 week SVR. Presumably because the relapse rate after 12 weeks was negligible.

SVR was negligible also .With Intron mono i believe it was 11 % and with Peg mono i think double that at around 25 % SVR Geno 1.Maybe with the orals the 12 wk EOT will be a valid time frame but i have not seen any conclusive data. Have you ?
Thanks